Dare to Innovate: Hepatitis C Models of Care
On-demand recorded 22 Jun 2021
The Australian Government has endorsed the World Health Organisation targets of 90% of people living with chronic HCV infection to be diagnosed, with 80% treatment coverage by 2030. Since the introduction of interferon-free direct acting antiviral (DAA) therapy on the Pharmaceutical Benefits Scheme in March 2016, an estimated 70, 260 people have been treated in Australia.
Australia is a world leader in progressing the elimination of HCV as a public health threat by 2030. A key feature of the Australian HCV treatment landscape since the DAA program commenced has been the involvement of non-specialists in prescribing.
Join Dr Joss O’Loan, Dr John Smart and Dr Robert Page for this interactive webinar that will explore innovative models of care with the aim to reinvigorate general practitioners’ engagement in prescribing DAA therapy for hepatitis C. After attending this webinar, attendees will identify patient barriers to testing and treatment and consider new strategies for connecting with the patient population to find and treat the remaining cases in Australia.
- Become aware of successful HCV models of care in Australia
- Identify patient barriers to HCV testing and treatment
- Consider new strategies for connecting with the patient population
This event attracts 3 CPD points
This event is part of ASHM Series. Events in this series are:
Dr Michael Burke
Michael Burke works in Western Sydney GP. He is committed to improving health equity, treatment and care for people with blood borne viruses including HIV. He works in whole person medicine framework, and enjoys getting to know his patients, reading, writing, and birdwatching.
Dr John Smart
General Practitioner, Addiction Medicine Specialist, Asquith Medical Centre
Dr Smart works in general practice in Hornsby and has dual interests in both Primary Care and Addiction Medicine. He was a Foundation Fellow of the Chapter of Addiction Medicine and has worked in major teaching hospitals and in the community in AOD. John has a very longstanding interest in the treatment of viral hepatitis and AOD teaching in the primary care setting.
Dr Joss O’Loan
General Practitioner, Kombi Clinic & Medeco Inala General Practice
Dr Joss O’Loan is a GP and co-founder of Kombi Clinic. When not working at his usual gig of Medeco Inala General Practice, he is driving around Brisbane in a 1975 Yellow Kombi van testing, treating, and curing Hep C in a variety of locations
Dr Robert Page
GP & Addiction Medicine Specialist
Rob is a GP and addiction medicine specialist in inner Sydney. Since 2014 he has worked primarily with populations at increased risk of blood-borne infections. He is experienced in the diagnosis and management of hepatitis C, and understands the challenges that HCV can present in General Practice.